Janssen Pharmaceutica N.V., Belgium
Quick facts
Marketed products
- early initiation of treatment with Risperdal Consta
- Risperidone Long acting injectable · Psychiatry/Neurology
Risperidone blocks dopamine D2 and serotonin 5-HT2A receptors in the brain to reduce psychotic symptoms and stabilize mood. - routine initiation of treatment with Risperdal Consta
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Janssen Pharmaceutica N.V., Belgium portfolio CI brief
- Janssen Pharmaceutica N.V., Belgium pipeline updates RSS
Frequently asked questions about Janssen Pharmaceutica N.V., Belgium
What are Janssen Pharmaceutica N.V., Belgium's marketed drugs?
Top marketed products include early initiation of treatment with Risperdal Consta, Risperidone Long acting injectable, routine initiation of treatment with Risperdal Consta.